Assignee
GENECRAFT INC
KR5 patents
Top patents by PatentIndex Score
US12414980B2Sep 16, 2025
Pharmaceutical composition comprising RUNX3 protein and CDK4 inhibitor or mTOR inhibitor cotreatment for prevention or treatment of cancer
GENECRAFT INC0 citations57
US11931401B2Mar 19, 2024
Runx3 modified protein for prevention or treatment of cancer
GENECRAFT INC0 citations57
US11891617B1Feb 6, 2024
Modified complex platform of adeno-associated virus with improved rate of expression of loaded genes and reduced genotoxicity
GENECRAFT INC0 citations52
US11767541B1Sep 26, 2023
Adeno-associated virus complex with improved expression of RUNX3 gene and uses for preventing or treating KRAS mutated lung cancer
GENECRAFT INC0 citations49
US11993783B1May 28, 2024
Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene, and use thereof
GENECRAFT INC0 citations41